Biodegradable sub‑conjunctival implant that delivers controlled anti-inflammatory medication after trabeculectomy or drainage‑tube surgery, replacing patient‑administered eye drops. Aims to reduce post‑operative complications and follow‑up burden for glaucoma surgery patients and surgeons, improving patient quality of life.